Group 1 - The company announced a share repurchase plan on August 4, with a total fund amounting to no less than 50 million yuan and no more than 100 million yuan [1] - The repurchase price will not exceed 8 yuan per share, and the implementation period is set to be within 12 months from the board's approval date [1] - As of July 31, 2025, the company has repurchased a total of 12.1049 million shares, accounting for 1.13% of the total share capital, with a total expenditure of 50.1949 million yuan (excluding transaction fees) [1]

Group 1 - The company ST Lianchuang (300343.SZ) announced a share buyback program, having repurchased a total of 12,104,900 shares as of July 31, 2025, which represents 1.13% of the total share capital [1] - The shares were repurchased through a special securities account via centralized bidding, with a maximum transaction price of 4.28 yuan per share and a minimum transaction price of 3.93 yuan per share [1] - The total amount spent on the share buyback reached approximately 50.194917 million yuan, excluding transaction fees [1]

二、其他说明 山东联创产业发展集团股份有限公司（以下简称"公司"）于 2025 年 4 月 8 日召 开第四届董事会第二十三次会议，审议通过《关于回购公司股份方案的议案》，同意公 司以自有资金通过集中竞价交易方式回购部分公司发行的人民币普通股（A 股）。本次 回购的资金总额不低于人民币 5,000 万元（含）且不超过人民币 10,000 万元（含）， 回购价格不超过人民币 8.00 元/股，实施期限自公司董事会审议通过最终回购股份方案 之日起不超过 12 个月。具体内容详见公司于 2025 年 4 月 8 日在巨潮资讯网 （www.cninfo.com.cn）披露的《关于回购公司股份方案的公告》（公告编号：2025-009）。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号 ——回购股份》的有关规定，回购期间，公司应当在每个月的前三个交易日内披露截至 上月末的回购进展情况。现将公司回购公司股份的情况公告如下： 一、回购公司股份的进展情况 截至 2025 年 7 月 31 日，公司通过回购专用证券账户，以集中竞价交易方式累计 回购公司股份 12,104,900 股，占目前公司总股本的 ...

2、根据《深圳证券交易所创业板股票上市规则（2024 年修订）》第 9.9 条 规定，公司因触及第 9.4 条第七项情形，其股票交易被实施其他风险警示期间， 应当至少每月披露一次差错更正进展公告，直至披露行政处罚决定所涉事项财务 会计报告更正公告及会计师事务所出具的专项核查意见等文件。 一、实施其他风险警示的原因 公司于 2025 年 3 月 19 日收到山东监管局下发的《行政处罚事先告知书》， 根据《事先告知书》认定的情况，公司涉及的违法违规行为触及《深圳证券交易 所创业板股票上市规则（2024 年修订）》第 9.4 条第一款第（七）项规定的被 实施其他风险警示情形，公司股票于 2025 年 3 月 25 日起被实施其他风险警示， 具体内容详见公司在巨潮资讯网上披露的《关于公司股票被实施其他风险警示暨 停复牌的公告》（公告编号：2025-006）。 二、采取的措施及进展情况 证券代码：300343 证券简称：ST联创 公告编号：2025-044 山东联创产业发展集团股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或 ...

证券代码：300343 证券简称：ST 联创 公告编号：2025-043 山东联创产业发展集团股份有限公司 关于控股股东部分股份解除质押的公告 截至公告披露日，上述股东所持质押股份情况如下： | | | | | | | | 已质押股份 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 累计被 | 占其所 | 占公司 | 情况 | | 情况 | | | 股东 名称 | 持股数 | 量 | 持股 比例 | 质押股 | 持股份 | 总股本 | 已质押股 份限售和 | 占已质 | 未质押 股份限 | 占未质 | | | | | | 份数量 | 比例 | 比例 | 冻结、标 | 押股份 比例 | 售和冻 | 押股份 比例 | | | | | | | | | 记数量 | | 结数量 | | | 李洪 | 1297218 | | 12.1 | 2213 万 | 17.06% | 2.07% | 0 | 0% | 0 | 0% | | 国 | 10 | 股 | 4% | 股 | | | | | ...

数据显示，截止7月29日，A股市场共有5817家上市公司。作为上市公司核心管理层关键成员，财务总 监CFO不仅需要确保公司财务稳健、资金高效运转，更需要从财务视角为公司的战略制定提供支撑，其 能力与决策直接影响公司的财务健康、战略成败、资本市场形象乃至生存风险。据2024年年报显示，去 年A股CFO（财务总监、财务负责人等）薪酬合计达42.43亿元，平均薪酬76.03万元。 基础化工行业财务总监2024年平均薪酬68.2万元 按年龄来看，基础化工行业上市公司财务总监平均年龄为47.43岁，年龄最大的是中研股份的财务总监 杨丽萍，现年63岁，2024年薪酬为66.6万元；年龄最小的是凯大催化（维权）的财务总监姚文轩，现年 30岁，2024年薪酬为27.36万元。 薪酬最高的财务总监为江瀚新材的侯贤凤，2024年度薪酬561.96万元，较上一年略微减少8.86万元。公 司经营业绩方面，江瀚新材2024年的营收、净利润分别为22.16亿元、6.02亿元，同比减少2.69%、 8.03%。 履历显示，侯贤凤2020年12月16日起任公司财务总监。曾任江汉有限技术员、技术部长、总经理助理、 副总经理；2020年12月至 ...

Investment Rating - The report maintains a recommendation for metals silicon, PBAT, and valine, indicating a positive outlook for these materials in the chemical industry [1]. Core Insights - The new materials sector outperformed the broader market and the basic chemical sector, with a weekly change of 1.37% for the new materials index compared to 1.17% for the basic chemical index and 1.09% for the CSI 300 index [8]. - Price increases were noted for metals silicon (+3.16%), PBAT (+0.51%), and valine (+0.35%), while significant declines were observed in electronic-grade hydrogen peroxide (-3.86%), 6F (-1.01%), and epoxy resin (-0.88%) [8][21]. - The report highlights the importance of the new materials sector, particularly in semiconductor materials, which showed significant gains [8][25]. Industry Updates - The Ministry of Industry and Information Technology held a meeting with photovoltaic companies to address low-price competition and promote the exit of outdated production capacity, aiming for sustainable development in the solar industry [9]. - The easing of trade tensions between China and the U.S. has led to a recovery in trade inquiries and shipping prices, positively impacting chemical prices [10]. - The report emphasizes the potential for growth in the new materials sector, particularly in areas that require domestic production capabilities and have been historically reliant on imports [11]. Trading Data - The Huachuang Chemical Industry Index stood at 73.06, reflecting a decrease of 0.22% week-on-week and a year-on-year decline of 25.03% [17]. - The industry inventory percentile is at 91.12%, indicating a high level of stock relative to the past five years [17].

Investment Rating - The report assigns an "Increase" rating for the industry [4]. Core Viewpoints - The second-generation refrigerant quota is set to be reduced as scheduled, while the third-generation refrigerant policy will continue, leading to an optimized supply-demand structure under quota constraints. Prices for second and third-generation refrigerants are expected to maintain an upward trend in 2025, indicating a favorable refrigerant market cycle. Domestic companies with strong comprehensive capabilities, complete product matrices, and advanced technology reserves will benefit from the refrigerant quotas [2][17]. Summary by Sections Market Review & Key Announcements - During the week of July 14-18, 2025, the fluorochemical sector saw significant stock price increases, with Zhongxin Fluorine Materials rising by 14.34%, Dongyue Group by 4.25%, and Yonghe Co. by 3.26% [7]. - Key announcements include Haohua Technology expecting a net profit of 590 million to 650 million yuan for H1 2025, a year-on-year increase of 10% to 21.18%. Juhua Co. anticipates a revenue of 11.712 billion yuan, a 27.29% increase year-on-year, with net profit projections of 1.970 billion to 2.130 billion yuan, reflecting a year-on-year growth of 136% to 155% [7][8]. Industry Dynamics: Refrigerant Price Trends - Refrigerant prices continue to rise, with R22 priced at 36,000 yuan/ton, R32 at 53,500 yuan/ton, R134A at 50,000 yuan/ton, and others showing varying weekly and monthly increases. The cost side shows stability with prices for raw materials like fluorite and sulfuric acid remaining relatively unchanged [10][11]. Inventory Levels and Operating Rates - Inventory levels are normal, with R22, R32, R134A, and R125 stocks at 4,165 tons, 3,843 tons, 3,305 tons, and 2,697 tons respectively, indicating a healthy supply situation. Operating rates for refrigerants have increased, with R22 at 55.42% and R32 at 66.20% as of June 2025 [12]. Demand Side: Production and Export Growth - The production of air conditioners reached 163.296 million units in the first half of 2025, a year-on-year increase of 3.97%, while exports totaled 41.05 million units, up 6.85% year-on-year [14]. Investment Recommendations - The report recommends investing in Juhua Co. and Dongyue Group, with related stocks including Sanmei Co., Haohua Technology, and Yonghe Co. These companies are expected to benefit from the favorable market conditions and strong domestic capabilities [17][18].

Group 1 - The capital market is experiencing a chain reaction, with Shandong Weiming Pharmaceutical Co., Ltd. (referred to as "Weiming Pharmaceutical") announcing significant stock price fluctuations and risk warnings due to abnormal trading activity [1] - Weiming Pharmaceutical expects a net loss attributable to shareholders of 55 million to 85 million yuan for the first half of 2025, representing a year-on-year decline of 85.72% to 187.02% [1] - The crisis is primarily due to the suspension of production and sales by its core subsidiary, Tianjin Weiming Biological Pharmaceutical Co., Ltd. (referred to as "Tianjin Weiming"), following a failure to meet GMP compliance requirements [1] Group 2 - Tianjin Weiming's production and sales of interferon drugs are the main source of revenue for Weiming Pharmaceutical, contributing 60% of the company's revenue in 2024 [2] - In 2024, Tianjin Weiming reported an operating income of 216 million yuan and a net loss of 14.0037 million yuan, significantly impacting Weiming Pharmaceutical's consolidated financial performance [2] - As of now, there are two A-share listed companies in Zibo under other risk warnings (ST), including Weiming Pharmaceutical and Shandong Lianchuang Industrial Development Group Co., Ltd. (referred to as "Lianchuang Shares") [2]

Group 1 - The PVDF concept sector experienced a decline of 1.65%, ranking among the top declines in concept sectors, with major declines seen in companies like Sanmei Co., Ltd., Juhua Co., Ltd., and Shenzhen New Star [1][2] - Among the PVDF concept stocks, only two stocks saw price increases, with Jinming Precision Machinery rising by 1.46% and ST Lianchuang by 0.59% [1][2] - The main capital outflow from the PVDF concept sector today was 297 million yuan, with 12 stocks experiencing net outflows, and six stocks seeing outflows exceeding 10 million yuan [2][3] Group 2 - Juhua Co., Ltd. had the highest net capital outflow of 123.45 million yuan, followed by Dongyangguang with 99.37 million yuan and Putailai with 22.80 million yuan [2][3] - The stocks with the highest net capital inflow included Haohua Technology, Jinming Precision Machinery, and Sanmei Co., Ltd., with inflows of 23.99 million yuan, 5.89 million yuan, and 3.76 million yuan respectively [2][3] - The trading volume for Juhua Co., Ltd. was 2.10%, while the trading volume for Jinming Precision Machinery was 4.04% [3]